HOME >> MEDICINE >> NEWS
Immune therapy could treat leukemias, autoimmune diseases, transplant rejection

DURHAM, N.C. -- In studies with mice, treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias, autoimmune diseases and transplant rejection, according to immunologists at Duke University Medical Center.

B cells are the immune system's "arms factories," producing antibodies that target invading microbes for destruction. Abnormal B cell proliferation causes such leukemias as multiple myeloma and acute lymphoblastic leukemia, and such autoimmune diseases as rheumatoid arthritis and lupus.

The researchers, led by Professor and Chair of Immunology Thomas Tedder, Ph.D., reported their findings in the online Early Edition of the Proceedings of the National Academy of Sciences the week of Oct. 10, 2005. Other co-authors of the paper were Norhito Yazawa, Yasuhito Hamaguchi and Jonathan Poe in Tedder's laboratory. The research was sponsored by the National Institutes of Health.

Monoclonal antibodies (mAbs) are those created to target a specific protein. In their studies, the Duke researchers used mAbs targeting a protein called CD19 that is found on the surface of B cells. As their experimental animal models, they used mice that had been genetically altered to produce a human version of the CD19 protein on their B cells.

Their studies demonstrated that CD19 mAbs did tag B cells containing that protein, and that these B cells were then destroyed by the immune system.

When the researchers administered the CD19 mAbs to the mice, they found that it greatly depleted mature B cells, as well as precursor and immature B cells in the animals. The depletion of precursor and immature B cells is important because aberrant versions of such cells cause a number of leukemias and other malignancies where new therapies are needed, said Tedder.

And, they found that giving the mice CD19 mAbs, along with a mAb that targets another B cell protein, CD20, resulted in additive
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University Medical Center
11-Oct-2005


Page: 1 2 3

Related medicine news :

1. Immune responses in trachoma, and more
2. Immune system police learn early and sometimes badly
3. Immune signals of variations of a single gene linked to more severe Crohns disease
4. Immune culprit in malaria-associated anemia
5. Immune system response to viral DNA is unique
6. Immune factor GM-CSF significantly improves Crohns disease symptoms
7. Immune system lab model overcomes ethical limits on human hematopoietic stem cells studies
8. Chemotherapy with bevacizumab increases risk of blood clots in arteries
9. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
10. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
11. Hormone therapy offers new hope for ovarian cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... TAMPA, Fla. (PRWEB) , ... September 03, 2020 ... ... today announced it is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual ... of a million people across hundreds of U.S. cities to raise awareness of ...
(Date:9/3/2020)... ... September 03, 2020 , ... MemoryCare.com, a comprehensive resource for ... Care Facilities in Louisville, KY. The guide identifies 17 memory care communities based ... the Alzheimer’s Association , 5.6 million people age 65 and older are ...
(Date:9/1/2020)... ... September 01, 2020 , ... Board ... in Glendale. While the office will be the first to bear her name, ... buttock augmentation (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, and many ...
(Date:9/1/2020)... ... September 01, 2020 , ... As fall and winter swiftly approach ... Health Institute has taken this time to expand and grow into a full-fledged ... the Cohn Health Institute will be relaunching its brand new website, expanding its services ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... Anniversary of Blood Cancer Awareness Month (BCAM) and its international Light it ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... 27, 2020 , ... Bleep LLC, maker of the DreamPort mask-less CPAP solution, ... company’s new spokesperson. , “In my line of work, a good night of sleep ... DreamPort it was a Bleeping no brainer for me,” said Jensen. “From the moment ...
(Date:8/26/2020)... ... August 26, 2020 , ... ScripHessco ... Sports Injuries. The infographic breaks down ways that chiropractors can help heal sports ... According to ScripHessco “Athletes have an unusual amount of pressure and stress on ...
(Date:8/26/2020)... ... August 26, 2020 , ... Clinical ... definitive agreement to acquire ProCE, a nationally recognized provider of continuing education ... , CEA represents a growing alliance of CME/CE and service organizations that ...
Breaking Medicine Technology:
Cached News: